Track your episodes and how they change using the Daily Tracker Tool. This will help your doctor determine if you’re taking the right amount.
KEVEYIS is a long-term treatment meant to be taken daily. Reach out to your doctor or our Patient Access Managers at any time on your KEVEYIS journey for support.
*The double-blind, placebo-controlled study of 9 weeks (N=65) was followed by a 1-year, open-label extension phase (N=58) in which all participants received KEVEYIS. The number, severity and duration of PPP attacks were assessed from weeks 2 to 9 of the double-blind, placebo-controlled study and during weeks 54 to 61 of the 1 year open-label extension.2
“Having better control over my PPP symptoms has meant I can engage more fully in my life. I can babysit my beautiful granddaughter, go out with friends, and have more independence. I worry much less now about falling or having to be rushed to the hospital.”
Setting treatment goals with your doctor is a great way to track your progress while on treatment.
Treatment goals should be specific to you and could include:
Use the Daily Tracker Tool to stay on top of your PPP management. Remember to keep your healthcare providers informed of your progress and any side effects.
By submitting this form, I understand I am giving Xeris Pharmaceuticals, Inc., its affiliates, and business partners permission to use the personal information provided in this registration form to contact me by the following methods, but not limited to: mail, email, telephone call or in-person about disease and product information, disease or product-related events, support services, market research, and to share promotional and marketing information. By submitting this form, I consent to these uses and am confirming that I have read and agree to the Xeris Pharmaceuticals® Terms of Use and Privacy Statement. I understand I can unsubscribe by clicking on the unsubscribe link in future communications or by sending a letter with my full contact information (eg, name, address, email, phone, etc) to Xeris CareConnection™ Patient Support Services, 1375 W Fulton Street, Suite 1300, Chicago, IL 60607.
KEVEYIS (dichlorphenamide) is a prescription drug used to treat primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and other similar diseases.
For more information, see full Prescribing Information for KEVEYIS.
Keveyis®, Xeris Pharmaceuticals®, Xeris CareConnection™, PPP MentorConnect™, and their associated logos are trademarks owned by or licensed to Xeris Pharmaceuticals, Inc.
By submitting this form, I understand I am giving Xeris Pharmaceuticals, Inc., its affiliates, and business partners permission to use the personal information provided in this registration form to contact me by the following methods, but not limited to: mail, email, telephone call or in-person about disease and product information, disease or product-related events, support services, market research, and to share promotional and marketing information. By submitting this form, I consent to these uses and am confirming that I have read and agree to the Xeris Pharmaceuticals® Terms of Use and Privacy Statement. I understand I can unsubscribe by clicking on the unsubscribe link in future communications or by sending a letter with my full contact information (eg, name, address, email, phone, etc) to Xeris CareConnection™ Patient Support Services, 1375 W Fulton Street, Suite 1300, Chicago, IL 60607.
